Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-006174)

Filing Details

Accession Number:: 0001209191-23-006174
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-02-02 16:00:11
Reporting Period:: 2023-01-31

Accepted Time:: 2023-02-02 16:00:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
879169	Incyte Corp	INCY	Services-Commercial Physical & Biological Research (8731)	943136539

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1736295	E Maria Pasquale	1801 Augustine Cut-Off Wilmington DE 19803	Evp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-01-31	802	$74.78	69,326	No	4	M	Direct
Common Stock	Disposition	2023-01-31	802	$84.06	68,524	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2023-01-31	802	$0.00	802	$74.78

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2032-01-18	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Includes an aggregate of 49,571 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
Beginning January 2, 2022, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2022 and the remainder vesting monthly over three years.